Institutions / Third Rock Ventures, LLC
Third Rock Ventures, LLC
CIK 1600135 · Institution · as of Dec 31, 2014
Portfolio value
$1.22B
Positions
6
As of
Dec 31, 2014
Holdings
Dec 31, 2014
| Company | Value | % of portfolio |
|---|---|---|
| Sage Therapeutics, Inc.SAGE | $427.52M | 35.0% |
| Agios Pharmaceuticals IncAGIO | $343.97M | 28.1% |
| Zafgen Inc. | $172.77M | 14.1% |
| bluebird bio, Inc. | $111.44M | 9.1% |
| Foundation Medicine, Inc. | $109.48M | 9.0% |
| Eleven Biotherapeutics, Inc. | $57.52M | 4.7% |
Activity
Dec 31, 2014
This fund's quarter-over-quarter position changes — what it's buying and selling.
No quarter-over-quarter changes yet. Position changes appear once we have two consecutive quarterly reports for this manager. We currently hold 1 quarter of holdings.